Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.



From the monthly archives: July, 2017

We are pleased to present below all posts archived in 'July, 2017'. If you still can't find what you are looking for, try using the search box.

The European Life Sciences Market – looking forward to continued growth

Horton International (UK), today launched its 2017 European Life Science Report, published following Horton’s annual survey amongst the movers and shakers within the European Life Science sector.

Read the rest of entry »

OBN announces EY as official host for inaugural BioSeed® conference

BioSeed®, a new conference created by OBN and Eurasanté, aims to showcase Europe’s most innovative early stage life sciences companies

26 July 2017, Abingdon, UK: OBN, the membership organisation supporting the UK’s innovative life sciences companies, is pleased to announce today that EY, global leader in assurance, tax, transaction and advisory services, has confirmed their support as Official Host of the first BioSeed® conference, taking place in London on 14 November 2017.

BioSeed® is the result of a shared vision between OBN and Eurasanté; with both parties aiming to fill the gap of industry events that solely support the interaction of early-stage companies with appropriate investors at a European level.

BioSeed® will run as a one-day event at EY's 1 More London Place office, on 14 November 2017 and will feature presentations and pitches by early-stage organisations and a series of pre-scheduled one-to-one meetings with potential investors.

Read the rest of entry »

Female Innovation Exhibition features OBN Member Fiona Marston, CEO of Absynth Biologics Limited

Canada Pension Plan Investment Board acquires 50% stake in Milton Park from Hermes

Hermes Investment Management (Hermes), the £30.8 billion manager, has agreed to sell a 50% equity stake in Milton Park to Canada Pension Plan Investment Board (CPPIB) for approximately £200 million.

Read the rest of entry »

Wickham Laboratories Announces successful MHRA Inspection

Wickham Laboratories reports a successful completion of the MHRA audit process and the subsequent renewal of the GLP accreditation.

Read the rest of entry »

Isansys Named as Finalist for Two Categories at the Celebration of Innovation Awards 2017

Isansys Lifecare Ltd is proud to announce it has been shortlisted for the Celebration of Innovation Awards 2017, a prestigious award celebrating the best of innovation in healthcare.

Read the rest of entry »

Leading French Lab Uses Skeletal Muscle Kit to Study Duchenne Myopathy

AMSBIO reports on an independent evaluation and use by I-Stem (Corbeil-Essonnes, France) of the Skeletal Muscle Differentiation kit - a cell culture media system to differentiate human stem cells into functional myotubes.

Read the rest of entry »

FDA Advisory Committee Unanimously Recommends CTL019 (tisagenlecleucel) for Approval

Oxford BioMedica (LSE:OXB) is a leading gene and cell therapy group focused on developing life changing treatments for serious diseases. 

Read the rest of entry »

PCI Reinforces Ongoing Commitment to Serialization in Response to Delayed Enforcement of FDA Deadline

PCI Pharma Services (PCI) has affirmed its position relative to the delayed enforcement of the US Food and Drug Administration (FDA)’s Compliance Policy for ‘Product Identified Requirements Under the Drug Supply Chain Security Act' (DSCSA).

Read the rest of entry »

Price cut secures a place for Ipsen’s Cabomeytx on the NHS

Ipsen has cut the price of its kidney cancer Cabometyx to help secure its place within the NHS’ routine commissioning stream, helping to over-turn a previous decision that it did not represent value for money.

Read the rest of entry »

Pages: Previous123NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.

OBN Noticeboard

This is an impromptu noticeboard to let people know about events, other things that are happening, perhaps lab equipment for sale etc.  Just drop an email to us, team@obn.org.uk, and we will post.